Literature DB >> 17525653

Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis.

Mona Harissi-Dagher1, Bilal F Khan, Debra A Schaumberg, Claes H Dohlman.   

Abstract

PURPOSE: Necrosis, melt, and perforation have historically been frequent around a Keratoprosthesis (KPro), even resulting in extrusion or endophthalmitis. Autoimmune diseases such as Stevens-Johnson Syndrome (SJS) and Ocular Cicatricial Pemphigoid (OCP) have been notorious in this respect. The purpose of this study was to compare the frequency of tissue melt after implantation of two designs of the Boston KPro, one allowing much better access of nutrition from the aqueous humor to the carrier graft.
METHODS: We retrospectively reviewed charts of 157 eyes implanted since 1990 with a poly (methylmethacrylate) Boston KPro, including 79 eyes implanted with the model having 8 small (1.3-mm diameter) holes in the back plate, and 78 eyes implanted with the older solid back plate. We compared the frequency of tissue melts between the two KPro designs, for all implants as well as for subgroups based on preoperative diagnosis.
RESULTS: In total, 48/157 eyes (31%) developed some degree of tissue melt around the stem, including 8/79 eyes (10%) in the back plate with holes group and 40/78 eyes (51%) in the solid back plate group (P < 0.0001). Among the melts in the back plate with holes group, 4/8 (50%) suffered from an underlying autoimmune disease such as SJS or OCP.
CONCLUSIONS: The Boston KPro design with a back plate containing holes protects the overlying corneal tissue from necrosis and melts. This improved situation is likely due to increased aqueous access and better nutrition to the corneal graft cells. In addition, this study confirms earlier work regarding the particular corneal fragility of patients with autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525653     DOI: 10.1097/ICO.0b013e318041f0a6

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  21 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Matrix metalloproteinase-9 expression in the Seoul-type keratoprosthesis implanted corneas with concurrent cultivated autologous oral mucosal epithelial cell transplantation.

Authors:  Sang-Mok Lee; Mee-Kum Kim; Mi-Sun Shin; Won-Ryang Wee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-18       Impact factor: 3.117

3.  Boston Keratoprosthesis: expanding the boundaries.

Authors:  Mona Harissi-Dagher
Journal:  Digit J Ophthalmol       Date:  2011-11-03

4.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Masako Chen; Sueko M Ng; Esen K Akpek; Sumayya Ahmad
Journal:  Cochrane Database Syst Rev       Date:  2020-05-13

Review 5.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Esen K Akpek; Majed Alkharashi; Frank S Hwang; Sueko M Ng; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2014-11-05

6.  Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials.

Authors:  Irmgard Behlau; Koushik Mukherjee; Amit Todani; Ann S Tisdale; Fabiano Cade; Liqiang Wang; Elizabeth M Leonard; Fouad R Zakka; Michael S Gilmore; Frederick A Jakobiec; Claes H Dohlman; Alexander M Klibanov
Journal:  Biomaterials       Date:  2011-09-07       Impact factor: 12.479

7.  The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA.

Authors:  Jared D Ament; Sandra J Spurr-Michaud; Claes H Dohlman; Ilene K Gipson
Journal:  Cornea       Date:  2009-08       Impact factor: 2.651

8.  Corneal graft dellen in a patient implanted with a Boston keratoprosthesis type 1.

Authors:  Riccardo Scotto; Aldo Vagge; Carlo E Traverso
Journal:  Int Ophthalmol       Date:  2016-04-11       Impact factor: 2.031

9.  UV cross-linking of donor corneas confers resistance to keratolysis.

Authors:  Samer N Arafat; Marie-Claude Robert; Anita N Shukla; Claes H Dohlman; James Chodosh; Joseph B Ciolino
Journal:  Cornea       Date:  2014-09       Impact factor: 2.651

10.  [Results with the Boston keratoprosthesis].

Authors:  B Koller; T Neuhann; I Neuhann
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.